After Covishield, the Bharat Biotech Private Limited manufactured, COVAXIN is also likely to receive Emergency Use Listing by the World Health Organisation (WHO) soon. With this, it would be enabling…
Another announcement was made by the Hyderabad based Bharat Biotech International Private Limited over the use of COVAXIN. The Bharat Biotech said the India made COVAXIN for the Novel Coronavirus…
The Hyderabad based pharma company, Bharat Biotech International Private limited agreed to pay compensation if shows adverse side effects on people. Vaccine recipients receiving Bharat Biotech manufactured COVAXIN, would have…
Balram Bhargava, the Chief of the Indian Council of Medical Research (ICMR) asked the Bharat Biotech International Private Limited to take consent from volunteers. On the 5th of January, the…
The first batch of COVAXIN has been dispatched to the Central Government for further distribution. The Hyderabad based Bharat Biotech International Private Limited pharma company sent the first batch on…
The Telugu Desam Party (TDP) President N. Chandrababu Naidu congratulated the scientists and their teams for developing the vaccine to the covid epidemic that is gripping the world. It is…
The Hyderabad based Bharat Biotech finally on the 3rd of January got approval for emergency use of COVAXIN, a potential candidate for the Novel Coronavirus infection. In regard to this,…
Hyderabad based pharma company, Bharat Biotech International Private Limited and the Indian Council Medical Research (ICMR) prepared vaccine, for the Novel Coronavirus or COVID-19 entered the third phase of the…
The Nizam’s Institute of Medical Sciences (NIMS) of Hyderabad started the phase-III human clinical trials for COVAXIN. The trials begin from the 16th of November. A medical team at NIMS…
On the 12th of September, Hyderabad based Bharat Biotech’s Novel Coronavirus or COVID-19 vaccine candidate COVAXIN, showed successful results on animals. According to the sources, the potential vaccine showed efficacy…
